Heron Therapeutics is trading at $0.31, up 5.52%, with no clear company-specific catalyst identified for September 29, 2026.

  • The available news search surfaced no clear company-specific announcement; the releases page showed no newer release than August 17.
  • Broader indexes were mixed, with no strong same-direction move to explain the gain. Its cause remains unexplained by available evidence.